Passage: HMPV causes milder illness with deaths being very rare and with no long-term post-viral symptoms. Question: Which of the following conclusions is/are valid? 1. Though SARS-CoV-2 and HMPV are similar viruses with somewhat different epidemiology, the former became a pandemic because it was novel and people had not been exposed to it in the past. 2. The two viruses have fundamentally different impacts on human populations and should not therefore be dealt with in a similar manner. Select the answer using the code given below.

Correct Answer: B (2 only)

Statement 1 is incorrect. Biologically, Human metapneumovirus (HMPV) and SARS-CoV-2 are not "similar viruses". HMPV, first identified in 2001, belongs to the Pneumoviridae family (closely related to the Respiratory Syncytial Virus or RSV), whereas SARS-CoV-2 belongs to the Coronaviridae family. Furthermore, from a logical deduction standpoint, asserting that SARS-CoV-2 became a pandemic solely because of its "novelty" relies on external assumptions not provided in the passage text, making it an invalid conclusion.

Statement 2 is valid. The passage explicitly highlights that HMPV causes "milder illness with deaths being very rare and with no long-term post-viral symptoms." This contrasts fundamentally with the documented population impacts of SARS-CoV-2, which triggered massive global fatalities, severe respiratory distress, and long-term health complications known as "Long COVID". Because these two pathogens affect human populations in fundamentally different ways—HMPV being a routinely circulating, mostly mild seasonal illness—the logical conclusion is that they should not be managed with similar public health policies. HMPV does not require the pandemic-era lockdowns, widespread quarantines, or emergency mandates utilized during the COVID-19 pandemic.

Takeaway: Always evaluate scientific taxonomy and distinct clinical outcomes in Science & Technology questions. HMPV (Pneumoviridae) and SARS-CoV-2 (Coronaviridae) have fundamentally different morbidity and mortality profiles, necessitating vastly different medical and administrative responses.